 IRVINE, Calif., July 27, 2021 GLOBE NEWSWIRE -- Oncocyte Corporation Nasdaq: OCX, a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that it will release its financial and operating results for the second quarter ended June 30, 2021, on Tuesday, August 10, 2021, after the close of the U.S. financial markets. The Company will host a conference call on Tuesday, August 10, 2021, at 4:30 pm ET 1:30 pm PT to discuss the results along with recent corporate developments. 